StonvexLoading…
StonvexStonvexStonvexCore line items from XOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $45.99M | $55.96M | $44.52M | $36.38M |
Operating Income | $-33.08M | $-45.87M | $-64.97M | $-111.35M |
Net Income | $-25.32M | $-50.16M | $-75.84M | $-73.33M |
EPS (Diluted) | $-2.71 | $-6.69 | $-13.11 | $-13.32 |
Total Assets | $60.36M | $98.33M | $93.68M | $189.94M |
Total Liabilities | $37.08M | $64.72M | $48.49M | $77.86M |
Cash & Equivalents | $14.04M | $11.00M | $11.64M | $35.63M |
Free Cash Flow OCF − CapEx | $5.37M | $-49.10M | $-40.67M | $-142.07M |
Shares Outstanding | 11.40M | 8.05M | 5.94M | 5.63M |